tiprankstipranks
Arcellx Inc (ACLX)
NASDAQ:ACLX
US Market
ACLX
Arcellx Inc
RESEARCH TOOLSreports
Want to see ACLX full AI Analyst Report?

Arcellx Inc (ACLX) Stock News & Sentiment

314 Followers
Arcellx Advances Anito-cel as FDA Accepts BLA Filing
Premium
Company Announcements
Arcellx Advances Anito-cel as FDA Accepts BLA Filing
2M ago
8K
ACLX
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
2M ago
AMC
AMD
Arcellx Stock (ACLX) Rockets on a Massive Deal with Gilead Sciences (GILD)
Premium
Market News
Arcellx Stock (ACLX) Rockets on a Massive Deal with Gilead Sciences (GILD)
2M ago
ACLX
GILD
M&A News: Arcellx Stock (ACLX) Booms 70% after Gilead Buys Cancer-Fighting Biotech for $7.8B
Premium
Market News
M&A News: Arcellx Stock (ACLX) Booms 70% after Gilead Buys Cancer-Fighting Biotech for $7.8B
2M ago
ACLX
GILD
Arcellx: Differentiated D-Domain BCMA CAR-T Profile and Safety Advantages Underpin Buy Rating and 58% Upside Potential
Premium
Ratings
Arcellx: Differentiated D-Domain BCMA CAR-T Profile and Safety Advantages Underpin Buy Rating and 58% Upside Potential
3M ago
ACLX
Positioning Arcellx for a Pivotal 2026: Anito-cel’s Differentiated Safety, Best-in-Class CAR T Launch Potential, and Undervalued Entry Point
Premium
Ratings
Positioning Arcellx for a Pivotal 2026: Anito-cel’s Differentiated Safety, Best-in-Class CAR T Launch Potential, and Undervalued Entry Point
3M ago
ACLX
3 ‘Strong Buy’ Stocks to Buy Today,12/23/2025, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Today,12/23/2025, According to Top Analysts
4M ago
ACLX
CGON
More ACLX News >

ACLX News on the Web

Gilead receives all required regulatory approvals for Arcellx acquisition
TipRanks News
Bullish
Gilead extends tender offer to acquire Arcellx
TipRanks News
Bullish
Piper Sandler Remains a Hold on Arcellx Inc (ACLX)
TipRanks News
Neutral
Gilead Strengthens Inflammation Portfolio With Ouro Medicines Deal
Zacks
Bullish
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal
The Motley Fool
Bullish
Will GILD's Move to Acquire ACLX Boost Its Cell Therapy Franchise?
Zacks
Bullish
Truist Financial Keeps Their Hold Rating on Arcellx Inc (ACLX)
TipRanks News
Neutral
Arcellx downgraded to Hold from Buy at TD Cowen
TipRanks News
Bearish

News Score - Last 7 Days

Neutral
ACLX
Sector Average
Media Buzz
This Week1 articles
Weekly Average0.75 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ACLX’s Media Buzz Sentiment?
1 articles about ACLX were published this week. In an average week, 0.75 articles are published.
    What is ACLX’s weekly average amount of articles?
    In an average week, 0.75 articles about ACLX are published.
      What is ACLX’s News Sentiment?
      100% of articles about ACLX were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week